Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Refractory Immune-Related Adult Epilepsy
NCT01545518Phase 2Terminated
- Sponsor
- Emory University
- Start
- Nov 2011
- Primary completion
- Jun 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of immune globulin in epilepsy and autoimmune epilepsy, sponsored by Emory University. Primary endpoint: Immune Abnormalities. Started Nov 2011; status: terminated.
02
Drugs
immune globulin
03
Conditions
epilepsyautoimmune epilepsy
Beyond the preview
Go deeper on NCT01545518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01545518.